
Unpatchable usbliter8 Shakes Apple Trust
Paradigm Shift’s usbliter8 exploit exposes an unfixable SecureROM flaw in Apple A12 and A13 chips, undermining the boot chain and reshaping hardware threat models.

Paradigm Shift’s usbliter8 exploit exposes an unfixable SecureROM flaw in Apple A12 and A13 chips, undermining the boot chain and reshaping hardware threat models.

Over 70 health workers in the DRC have contracted Ebola as a fast-spreading outbreak collides with aid cuts, unsafe water and crowded displacement camps.
2026-06-20

The Trump administration is moving to loosen federal controls on testosterone, igniting a clash among doctors, regulators, and patient groups over safety, access, and the politics of masculinity.
2026-06-20

Apple is dropping many older Watches from watchOS 27 because silicon, sensors and on‑device AI workloads have outgrown legacy chips, batteries and radios.
2026-06-20

A six-month-old girl who died from Ebola has been buried in eastern Congo, becoming the third child from the same orphanage to succumb during the current outbreak.
2026-06-20

Nothing has scrapped this cycle’s CMF phone after mobile DRAM prices surged, pushing its next budget handset slot to a distant, undefined window.
2026-06-20

Health officials report a measles exposure involving an infected traveler who passed through LAX and a nearby Hilton, urging passengers and guests to review their immunity and monitor symptoms.
2026-06-20

A new interdisciplinary study uses ancient DNA and skeletal evidence to argue that plague history is far older, slower, and more regionally diverse than standard outbreak narratives suggest.
2026-06-20

Aura’s new e‑ink photo frame rejects the glossy, techy look, using a matte e‑ink panel and restrained hardware design to make a familiar gift feel unexpectedly analog.
2026-06-20

Android 17 is disrupting 5G and eSIM on some Pixel phones, with users reporting lost networks and missing profiles as Google investigates and tests a software remedy.
2026-06-20

Some cancer patients are rejecting chemotherapy in favor of ivermectin, despite no clinical proof of benefit and clear toxicity risks, leaving oncologists scrambling to counter viral misinformation.
2026-06-19